Management of primary pterygia using free conjunctival and limbal-conjunctival autografts without antimetabolites

Cornea

Volumn 24, Issue 8, 2005, Pages 972-975

  Mejía, Luis F ^a,b   Sánchez, Juan G ^a   Escobar, Héctor ^a  

^a UNIVERSIDAD CES   (Colombia)

^b Clinica SOMA   (Colombia)

Author keywords

Aerorotor; Antimetabolites; Free conjunctival autograft; Pterygium

Indexed keywords

ANTIMETABOLITE;

ADULT; AGED; ARTICLE; AUTOGRAFT; CONJUNCTIVA; CORNEA LIMBUS; FEMALE; FOLLOW UP; FREE TISSUE GRAFT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PTERYGIUM; RECURRENCE RISK; SURGICAL TECHNIQUE;

ADULT; AGED; ANTIMETABOLITES; CONJUNCTIVA; CORNEAL TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIMBUS CORNEAE; MALE; MIDDLE AGED; PTERYGIUM; RECURRENCE; RETROSPECTIVE STUDIES; SURGICAL FLAPS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 28044440539     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000160971.96447.9e     Document Type: Article

References (64)

1. Adamis AP, Starck T, Kenyon KR. The management of pterygium. Ophthalmol Clin North Am. 1990;3:611-623.
2. Mackenzie FD, Hirst LW, Battistutta D, et al. Risk analysis in the development of pterygia. Ophthalmology. 1992;99:1056-1061.
3. Cameron ME. Pterygium Throughout the World. Springfield, IL: Charles C Thomas; 1965:141.
4. Rojas JR, Málaga H. Pterygium in Lima, Perú. Ann Ophthalmol. 1986;18: 147-149.
5. Barraquer JI. Etiología y patogenia del pterigion y de las excavaciones de la córnea de fuchs. Arch Soc Am Oftal Optom. 1964;5:49-60.
6. Hilgers JH. Pterygium: its incidence, heredity and etiology. Am J Ophthalmol. 1960;50:635-644.
7. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 1999;10:282-288.
8. Chowers I, Peer J, Zamir E, et al. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology. 2001;108:985-988.
9. Rosenthal JW. Chronology of pterygium therapy. Am J Ophthalmol. 1953; 36:1601-1606.
10. Tan Donald TH, Chee S-P, Dear Keith BG, et al. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival auto grafting with bare sclera excision. Arch Ophthalmol. 1997; 115:1235-1240.
11. Gibson JBG. Brisbane survey of pterygium. Trans Ophthalmol Soc Aust. 1956;16:125-127.
12. Lei G. Surgery for pterygium using a conjunctival pedunculated flap slide. Br J Ophthalmol. 1996;80:33-34.
13. McCoombes JA, Hirst LW, Isbell GP. Sliding conjunctival flap for the treatment of primary pterygium. Ophthalmology. 1994;101:169-173.
14. Desmarres LA. Traite Theorique et Pratique des Maladies des Yeu, 2nd ed. Paris: G. Baillere; 1855:128.
15. Knapp H. A new plastic conjunctival operation. Arch Ophthalmol. 1868; 14:270-272.
16. McReynolds JO. The nature and treatment of pterygia. JAMA. 1902;39: 296-299.
17. Mackenzie FD, Hirst LW. Recurrence rate and complications after beta irradiation for pterygia. Ophthalmology. 1991;98:1776-1781.
18. Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985;92:1461-1470.
19. Serrano F. Plastia conjuntival libre en la cirugía del pterigion. Arch Soc Am Oftal Optom. 1977;12:97-102.
20. Kenyon KR, Tseng SCG. Limbal autograft transplantation for ocular surface disorders. Ophthalmology. 1989;96:709-723.
21. Shimazaki J, Yang HY, Tsubota K. Limbal autograft transplantation for recurrent and advanced pterygia. Ophthalmic Surg Lasers. 1996;27: 17-23.
22. Barraquer JI. The corneo-conjunctival limbus reconstruction before corneal grafting. In: King JH, McTigue J, eds. Proceedings of the First Corneal World Congress. Washington DC: Butterworths; 1965.
23. Prabhasawat P, Barton K, Burkett G, et al. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology. 1997;104:974-985.
24. Figueiredo RS, Cohen EJ, Gomes JAP, et al. Conjunctival autograft for pterygium surgery. Ophthalmic Surg Lasers. 1997;28:99-104.
25. Lewallen S. A randomized trial of conjunctival auto grafting for pterygium in the tropics. Ophthalmology. 1989;96:1612-1614.
26. Gris O, Güell JL, del Campo Z. Limbal-conjunctival autograft transplantation for the treatment of recurrent pterygium. Ophthalmology. 2000; 107:270-273.
27. Guler M, Sobaci G, Ilker S, et al. Limbal-conjunctival autograft transplantation in cases with recurrent pterygium. Acta Ophthalmol Scand (Copenh). 1994;72:721-726.
28. Salomon A, Pires RTF, Tseng SCG. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology. 2001;108:449-460.
29. Manning CA, Kloess PM, Diaz MD, et al. Intraoperative mitomycin in primary pterygium excision. Ophthalmology. 1997;104:844-848.
30. Frucht-Pery J, Siganos CS, Ilsar M. Intraoperative application of topical mitomycin-C for pterygium surgery. Ophthalmology. 1996;103:674-677.
31. Sharma A, Gupta A, Ram J. Low-dose intraoperative mitomycin-C versus conjunctival autograft in primary pterygium surgery: long term follow-up. Ophthalmic Surg Lasers. 2000;31:301-317.
32. Pikkel J, Porges Y, Ophir A. Halting pterygium recurrence by post-operative 5-fluorouracil. Cornea. 2001;20:168-171.
33. Hardman JG, Limbird LE, Molinoff PB, et al. Goodman & Gilman's Las Bases Farmacológicas de la Terapéutica, 9th ed. Mexico D.F.: McGraw-Hill Interamericana 1996:1347-1348.
34. Rubinfield RS, Stein RM. Topical mitomycin-C for pterygia: is single application appropriate? Ophthalmic Surg Laser. 1997;28:662-669.
35. Panda A, Das GK, Tuli SW, et al. Randomized trial of intraoperative mitomycin C in surgery for pterygium. Am J Ophthalmol. 1998;125: 59-63.
36. Frutch-Pery J, Siganos CS, Ilsar M. Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology. 1996;103:674-677.
37. Frutch-Pery J, Ilsar M, Hemo I. Single dosage mitomycin C for prevention of recurrent pterygium: a preliminary report. Cornea. 1994;13:411-413.
38. Wong VA, Law FC. Use of mitomycin C with conjunctival autograft in pterygium surgery in Asian-Canadians. Ophthalmology. 1999;106:1512-1515.
39. Anduze AL, Burnett JM. Indications for and complications of mitomycin-C in pterygium surgery. Ophthalmic Surg Lasers. 1996;27:667-673.
40. Frutch-Pery J, Ilsar M. The use of low-dose mitomycin C for prevention of recurrent pterygium. Ophthalmology. 1994;101:759-762.
41. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99: 1647-1654.
42. Fukamachi Y, Hikita N. Ocular complication following pterygium operation and instillation of mitomycin C. Folia Ophthalmol Jpn. 1981;32: 197-201.
43. Yamanouchi U, Mishima K. Eye lesions due to mitomycin C instillation after pterygium operation. Folia Ophthalmol Jpn. 1967;18:854-861.
44. Sugar A. Who should receive mitomycin-C after pterygium surgery? [editorial]. Ophthalmology. 1992;99:1645-1646.
45. Lin CP, Shih MH, Tsai MC. Clinical experiences of infectious scleral ulceration: a complication of pterygium operation. Br J Ophthalmol. 1997;81:980-983.
46. Dunn JP, Seamone CD, Ostler HB, et al. Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy. Am J Ophthalmol. 1991;112:343-344.
47. Kassir MS. Corneal perforation after excision of pterygium and use of 0.02% mitomycin eyedrops. J Fr Ophtalmol. 1999;22:776-779.
48. Tsai YY, Lin JM, Shy JD. Acute scleral thinning after pterygium excision with intraoperative mitomycin C: a case report of scleral dellen after bare sclera technique and review of the literature. Cornea. 2002;21:227-229.
49. Reinoso S. Cirugía del pterigion mediante Aerorotor. Arch Soc Am Oftal Optom. 1977;12:109-130.
50. Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis. Graefes Arch Clin Exp Ophthalmol. 1998;236:702-708.
51. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-β and TNF-α in the pterygium. Acta Histochem. 1996;98: 195-201.
52. Barraquer JI, Binder PS, Buxton JN, et al. Etiology and treatment of the pterygium. In: Symposium on Medical and Surgical Diseases of the Cornea. Transactions of the New Orleans Academy of Ophthalmology. St Louis: CV Mosby; 1980:167-178.
53. Hayasaka S, Noda S, Yamamoto, et al. Postoperative instillation of mitomycin C in the treatment of recurrent pterygium. Ophthalmic Surg. 1989;20:580-583.
54. Bowman WC, Rand MJ, eds. Textbook of Pharmacology, vol 3, 2nd ed. New York/Oxford: Blackwell; 1980:14-15.
55. Tarr KH, Constable IJ. Late complications of pterygium treatment. Br J Ophthalmol. 1980;64:496-505.
56. Tseng SCG. Concept and application of limbal stem cells. Eye. 1989;3: 141-157.
57. Lavker RM, Costarelis G, Dong G, et al. Limbal location of corneal epithelial stem cells. In: Cavanagh D, ed. The Cornea: Transactions of the World Congress on the Cornea III. New York: Raven Press; 1988:23-25.
58. Cheng HC, Tseng SH, Kao PL, et al. Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery. Cornea. 2001;20:24-29.
59. Safianik B, Ben-Zion I, Garzozi HJ. Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol. 2002;86: 357-358.
60. Hayasaka S, Iwasa Y, Nagaki Y, et al. Late complications after pterygium excision with high dose mitomycin C instillation. Br J Ophthalmol. 2000; 84:1081-1082.
61. Tseng SCG, Chen JJY, Wang AJW. Classification of conjunctival surgeries for corneal diseases based on stem cell concept. Ophthalmol Clin North Am. 1990;3:595-610.
62. Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol. 1999;83:748-752.
63. Mejía LF, Acosta C, Santamaría JP. Use of nonpreserved human amniotic membrane for the reconstruction of the ocular surface. Cornea. 2000;19: 288-291.
64. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol. 1998;82:235-240.